GRACE

cancergrace.org

 

GRACE
M

2020 Update on the Prevalence & Epidemiology of Blood Cancers: Aggressive/Indolent Disease, Prior Therapies, Gender/Age Distribution, Most Common Subtypes

By GRACE FEATURING Marco Ruiz
By GRACE FEATURING Marco Ruiz
12 views
December 14, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

19:39
Pfizer Hematology

Making the First Chance Count: Manuel

Feat. A. Ip

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison
Hematologic Oncology
08:59

Emerging IO Treatments for B-Cell Non-Hodgkins Lymphoma: CAR-T Cells

GRACE

J. Brody

18 views
04:37

Emerging IO Treatments for B-Cell Non-Hodgkins Lymphoma: Bispecific …

GRACE

J. Brody

7 views
04:08

CAR T-Cell Therapy Side Effects for Blood Cancers

GRACE

A. Goodman

2.3K views
03:48

Emerging Types of CAR T-Cell Therapy for Blood Cancers

GRACE

A. Goodman

16 views
06:51

2020 Update on the Prevalence & Epidemiology of Blood Cancers: Aggre…

GRACE

M. Ruiz

12 views
08:13

2020 Update on Blood Cancer Diagnosis: Morphology, Cytogenetic/Molec…

GRACE

M. Ruiz

353 views
08:39

2020 Update Blood Cancers: IO vs. Chemo, Targeted Therapies, Bone Ma…

GRACE

M. Ruiz

14 views
05:11

2020 Update on R/R MCL: What Are the Outcomes from CAR-T Therapy? Re…

GRACE

J. Brody

56 views